Sutro Biopharma, Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-2.10 | — | — | Miss |
| Q12026 FY2026 | $-2.32 | $-2.94 | -26.7% | Miss |
| 2026-03-12 | $-4.66 | — | — | Miss |
Back to STRO overview · STRO holders · STRO KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.